Article

Peripheral CD8+CD28- T cell level reflects tumor immunity and could predict anti- HER2 based therapy response in metastatic breast cancer

2022-04-25

Abstract excerpt

<h4>Purpose: </h4> Despite recent clinical improvements, HER2-positive metastatic breast cancer (MBC) is still incurable. A robust biomarker is needed in predicting the efficacy of anti-HER2 based therapy. Experimental Design A total of 252 HER-positive MBC patients received first-line therapy were retrospectively recruited at two medical centers. Peripheral lymphocyte levels of baseline and subsequent follow-up v...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3a769ba1-19a4-526c-832e-b54d2506d3b4
DOI: 10.21203/rs.3.rs-1571322/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Peripheral CD8+CD28- T cell level reflects tumor immunity and could predict anti- HER2 based therapy response in metastatic breast cancerDOI 10.21203/rs.3.rs-1571322/v1Read

Predictive Role of Peripheral Blood Lymphocyte And Cytokine Phenotypes in Patients with Operable Breast Cancer And Neoadjuvant Therapy: A Preliminary StudySemantic proximity Read

TREM2+ macrophages regulate suppressive tumor microenvironment in TNBCSemantic proximity Read

Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy.Semantic proximity Read

Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.Semantic proximity Read

Tumoral PD-1hiCD8+ T cells are partially exhausted and predict favorable outcome in triple-negative breast cancer.Semantic proximity Read

p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancerSemantic proximity Read

MCT4 Upregulates PD-L1 Expression and Defines Novel Composite Therapeutic Targets for Triple-Negative Breast CancerSemantic proximity Read

Considering B7-CD28 as a family through sequence and structureSemantic proximity Read

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast CancerSemantic proximity Read

Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patientsSemantic proximity Read

Gene Expression Assay: A New Panel for Early Metastatic Risk Estimation for Breast CancerSemantic proximity Read

CD8-positive T cells are key immune cells for predicting the therapeutic effect of neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity Read